Ocular Therapeutix Inc

23 oct. 2026, 20:08 UTC

Ocular Therapeutix Inc shares fell amid a broader market decline, rising oil prices, and weak consumer sentiment reflected in October's University of Michigan reading.

21 oct. 2026, 20:07 UTC

Ocular Therapeutix Inc shares are declining, having sharply fallen after an early gain, and are currently trading below their 20-day moving average.

20 oct. 2026, 20:02 UTC

Piper Sandler projects Ocular Therapeutix could reach $1.3 billion in revenue by 2030, while Bank of America sets a price target of $27.

19 oct. 2026, 20:02 UTC

Bank of America sets a price target of $27 for Ocular Therapeutix, citing advantages of its drug Axpaxli and an upcoming NDA filing in Q4.

16 oct. 2026, 20:02 UTC

Ocular Therapeutix Inc shares fell sharply, facing significant volatility and trading near the lower end of its one-month range and below its 20-day moving average.

15 oct. 2026, 19:46 UTC

Ocular Therapeutix's investigational product AXPAXLI (OTX-TKI) could achieve $3.3 billion in sales by 2035, according to UBS, surpassing previous estimates.

14 oct. 2026, 23:11 UTC

Ocular Therapeutix Inc. is advancing modestly in after-market trading following Wednesday's close.

13 oct. 2026, 19:52 UTC

Ocular Therapeutix Inc is declining amid market weakness, despite a Buy rating from Bank of America with a price target of $27 and an upcoming NDA filing.

12 oct. 2026, 20:06 UTC

Ocular Therapeutix gains traction after UBS initiated coverage with a Buy rating and a price target of $14, projecting sales for Axpaxli to reach $3.3 billion by 2035.

9 oct. 2026, 20:07 UTC

Ocular Therapeutix Inc shares are advancing in Friday's trading session, showing modest gains since Thursday's close despite earlier pulling back from a midday high.

8 oct. 2026, 22:15 UTC

Ocular Therapeutix Inc shares are trading modestly lower in after-market hours, having reversed from an early gain and remaining below their 20-day moving average.

7 oct. 2026, 23:35 UTC

Ocular Therapeutix Inc is advancing in after-market trading, showing a notable increase since Wednesday's close despite remaining below its 20-day moving average.

6 oct. 2026, 22:55 UTC

Ocular Therapeutix Inc. traded modestly higher in after-market hours on Tuesday, recovering from an early dip despite a significant decline over the past month.

5 oct. 2026, 23:10 UTC

Ocular Therapeutix Inc's shares declined during after-market hours on Monday, following fluctuations earlier in the session and trading below its 20-day moving average.

2 oct. 2026, 23:05 UTC

Ocular Therapeutix Inc is trading higher in after-market hours, reflecting a notable upward trajectory following three consecutive lower finishes.

1 oct. 2026, 23:06 UTC

Ocular Therapeutix Inc is trading higher in after-market hours following a modest decline from its earlier high reached after the market closed.

30 sept. 2026, 23:35 UTC

Ocular Therapeutix Inc. is trading modestly higher in after-market hours, continuing an upward trend since Wednesday's close despite recent declines.

29 sept. 2026, 23:10 UTC

Ocular Therapeutix Inc. is trading higher in after-market hours, with a cumulative return of 0.76% after peaking at 1.51% following Tuesday's close.

28 sept. 2026, 23:01 UTC

Ocular Therapeutix Inc is trading higher in after-market hours, rebounding from an earlier session dip despite being below its 20-day moving average.

25 sept. 2026, 20:07 UTC

Ocular Therapeutix Inc shares fell sharply, marking the fourth consecutive session of lower closes and remaining well below the 20-day moving average.

24 sept. 2026, 20:07 UTC

Ocular Therapeutix Inc shares fell sharply, despite earlier gains, as the stock trades near the low end of its one-month range ahead of a presentation today.

23 sept. 2026, 20:02 UTC

Ocular Therapeutix Inc shares fell sharply, breaking a trend of higher daily closes since Tuesday, indicating a divergence from recent upward momentum.

22 sept. 2026, 20:07 UTC

Ocular Therapeutix Inc is advancing sharply during Tuesday's trading session, reflecting overall market strength, despite pulling back from an earlier peak.

21 sept. 2026, 23:10 UTC

Ocular Therapeutix Inc saw a modest increase in after-market trading, gaining ground since Monday's close, despite remaining below its 20-day moving average.

18 sept. 2026, 23:25 UTC

Ocular Therapeutix Inc is trading higher in after-market hours, rising from a low post-close and currently above Friday's close but below its 20-day moving average.

17 sept. 2026, 20:07 UTC

Ocular Therapeutix Inc is advancing, maintaining gains from Wednesday, despite earlier pulling back from a session high while remaining below its 20-day moving average.

16 sept. 2026, 20:10 UTC

Ocular Therapeutix Inc shares fell sharply despite positive social media sentiment about its NDA filing for Axpaxli and recent FDA discussions.

15 sept. 2026, 22:02 UTC

Ocular Therapeutix Inc. plans to submit its New Drug Application by Q4 2026, but shares are lower in after-market hours amid broader economic concerns.

14 sept. 2026, 19:17 UTC

Ocular Therapeutix Inc is trading higher during Monday's session, having gained since Friday's close, despite a negative broader market sentiment.

11 sept. 2026, 23:51 UTC

Ocular Therapeutix Inc shares are higher in after-market hours, supported by improved fiscal management reflected in a narrower-than-expected budget deficit of $167 billion for August.